FOLH1 and neoplasm: However, improved overall survival was only proven by VISION, which also recruited patients with small (< 1 cm visceral or < 2.5 cm lymph node) PSMA-negative tumor sites as long as larger lesions demonstrated uptake greater than liver [1, 93].